• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多变量变形分析脑萎缩以预测轻度认知障碍中的阿尔茨海默病

Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

作者信息

Teipel Stefan J, Born Christine, Ewers Michael, Bokde Arun L W, Reiser Maximilian F, Möller Hans-Jürgen, Hampel Harald

机构信息

Alzheimer Memorial Center, Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr 7, 80336, Munich, Germany.

出版信息

Neuroimage. 2007 Oct 15;38(1):13-24. doi: 10.1016/j.neuroimage.2007.07.008. Epub 2007 Jul 18.

DOI:10.1016/j.neuroimage.2007.07.008
PMID:17827035
Abstract

Automated deformation-based analysis of MRI scans can be used to detect specific pattern of brain atrophy in Alzheimer's disease (AD), but it still lacks an established model to derive the individual risk of AD in at-risk subjects, such as patients with mild cognitive impairment (MCI). We applied principal component analysis to deformation maps derived from MRI scans of 32 AD patients, 18 elderly healthy controls and 24 MCI patients. Principal component scores were used to discriminate between AD patients and controls and between MCI converters and MCI non-converters. We found a significant regional pattern of atrophy (p<0.001) in medial temporal lobes, neocortical association areas, thalamus and basal ganglia and corresponding widening of cerebrospinal fluid (CSF) spaces (p<0.001) in AD patients compared to controls. Accuracy was 81% for CSF- and 83% for brain-based deformation maps to separate AD patients from controls. Nine out of 24 MCI patients converted to AD during clinical follow-up. Discrimination between MCI converters and non-converters reached 80% accuracy based on CSF maps and 73% accuracy based on brain maps. In a logistic regression model, principal component scores based on CSF maps predicted clinical outcome in MCI patients even after controlling for age, gender, MMSE score and time of follow-up. Our findings indicate that multivariate network analysis of deformation maps detects typical features of AD pathology and provides a powerful tool to predict conversion into AD in non-demented at risk patients.

摘要

基于MRI扫描的自动变形分析可用于检测阿尔茨海默病(AD)中特定的脑萎缩模式,但仍缺乏一个既定模型来推导高危人群(如轻度认知障碍(MCI)患者)患AD的个体风险。我们将主成分分析应用于32例AD患者、18例老年健康对照者和24例MCI患者的MRI扫描变形图。主成分得分用于区分AD患者与对照者以及MCI转化者与MCI非转化者。我们发现,与对照者相比,AD患者的内侧颞叶、新皮质联合区、丘脑和基底神经节存在显著的萎缩区域模式(p<0.001),相应的脑脊液(CSF)间隙增宽(p<0.001)。基于CSF的变形图将AD患者与对照者分开的准确率为81%,基于脑的变形图为83%。24例MCI患者中有9例在临床随访期间转化为AD。基于CSF图,MCI转化者与非转化者之间的辨别准确率达到80%,基于脑图的准确率为73%。在逻辑回归模型中,即使在控制了年龄、性别、MMSE评分和随访时间后,基于CSF图的主成分得分仍能预测MCI患者的临床结局。我们的研究结果表明,变形图的多变量网络分析可检测AD病理的典型特征,并为预测非痴呆高危患者转化为AD提供了一个强大的工具。

相似文献

1
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.基于多变量变形分析脑萎缩以预测轻度认知障碍中的阿尔茨海默病
Neuroimage. 2007 Oct 15;38(1):13-24. doi: 10.1016/j.neuroimage.2007.07.008. Epub 2007 Jul 18.
2
Relating one-year cognitive change in mild cognitive impairment to baseline MRI features.轻度认知障碍患者的一年认知变化与基线MRI特征的相关性
Neuroimage. 2009 Oct 1;47(4):1363-70. doi: 10.1016/j.neuroimage.2009.04.023. Epub 2009 Apr 14.
3
Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.用于评估磁共振图像的视觉评分系统:一种诊断轻度认知障碍和阿尔茨海默病的工具。
J Comput Assist Tomogr. 2009 Jan-Feb;33(1):73-8. doi: 10.1097/RCT.0b013e31816373d8.
4
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.海马萎缩图谱预测轻度认知障碍向阿尔茨海默病的转化
Arch Neurol. 2006 May;63(5):693-9. doi: 10.1001/archneur.63.5.693.
5
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.利用基于体素的形态测量法绘制与轻度认知障碍快速转化相关的结构变化:一项纵向MRI研究。
Neuroimage. 2005 Oct 1;27(4):934-46. doi: 10.1016/j.neuroimage.2005.05.015.
6
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.从认知健康到轻度认知障碍和阿尔茨海默病的转变:由血浆β淀粉样蛋白42、内侧颞叶萎缩和同型半胱氨酸进行预测
Neurobiol Aging. 2008 Jan;29(1):1-11. doi: 10.1016/j.neurobiolaging.2006.09.002. Epub 2006 Oct 19.
7
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.多变量磁共振成像数据分析用于阿尔茨海默病、轻度认知障碍和健康对照。
Neuroimage. 2011 Jan 15;54(2):1178-87. doi: 10.1016/j.neuroimage.2010.08.044. Epub 2010 Aug 25.
8
Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.99mTc-ECD单光子发射计算机断层扫描(SPECT)与神经心理学研究相结合用于轻度认知障碍(MCI)向阿尔茨海默病(AD)转化的评估
Neurobiol Aging. 2006 Jan;27(1):24-31. doi: 10.1016/j.neurobiolaging.2004.12.010. Epub 2005 Mar 24.
9
Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).脑磁共振成像(MRI)上颞叶萎缩的线性测量,而非对白质变化的视觉评分,有助于区分轻度认知障碍(MCI)和阿尔茨海默病(AD)。
Arch Gerontol Geriatr. 2007 Mar-Apr;44(2):141-51. doi: 10.1016/j.archger.2006.04.006. Epub 2006 May 24.
10
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.联合rCBF和脑脊液生物标志物可预测从轻度认知障碍进展为阿尔茨海默病。
Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23.

引用本文的文献

1
Network spreading and local biological vulnerability in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的网络传播与局部生物易损性
Commun Biol. 2025 Aug 4;8(1):1153. doi: 10.1038/s42003-025-08561-3.
2
The Intersection of Genetics and Neuroimaging: A Systematic Review of Imaging Genetics in Neurological Disease for Personalized Treatment.遗传学与神经影像学的交叉:神经系统疾病影像遗传学用于个性化治疗的系统综述
J Mol Neurosci. 2025 May 13;75(2):66. doi: 10.1007/s12031-025-02350-7.
3
Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health.
揭开肠道-大脑关联之谜:微生物群相关结构脑生物标志物与行为和心理健康的关联。
Psychiatry Clin Neurosci. 2024 Jun;78(6):339-346. doi: 10.1111/pcn.13655. Epub 2024 Feb 29.
4
Whole-brain structure-function coupling abnormalities in mild cognitive impairment: a study combining amplitude of low-frequency fluctuations and voxel-based morphometry.轻度认知障碍中的全脑结构-功能耦合异常:一项结合低频波动幅度和基于体素的形态学测量的研究
Front Neurosci. 2023 Jul 31;17:1236221. doi: 10.3389/fnins.2023.1236221. eCollection 2023.
5
Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis.阿尔茨海默病、酒精使用障碍和双重诊断个体的认知功能障碍和脑容量缺陷。
Psychiatry Res Neuroimaging. 2021 Nov 30;317:111380. doi: 10.1016/j.pscychresns.2021.111380. Epub 2021 Aug 29.
6
Prediction of the progression from mild cognitive impairment to Alzheimer's disease using a radiomics-integrated model.使用放射组学整合模型预测从轻度认知障碍到阿尔茨海默病的进展。
Ther Adv Neurol Disord. 2021 Jul 15;14:17562864211029551. doi: 10.1177/17562864211029551. eCollection 2021.
7
deletion and a rare variant associated with late onset Alzheimer's disease trigger BACE1 accumulation in axonal swellings.缺失和一个与晚发性阿尔茨海默病相关的罕见变异导致 BACE1 在轴突肿胀中积累。
Sci Transl Med. 2020 Nov 18;12(570). doi: 10.1126/scitranslmed.aba1871.
8
Denouements of machine learning and multimodal diagnostic classification of Alzheimer's disease.机器学习与阿尔茨海默病多模态诊断分类的结局
Vis Comput Ind Biomed Art. 2020 Nov 5;3(1):26. doi: 10.1186/s42492-020-00062-w.
9
Disconnection of the right superior parietal lobule from the precuneus is associated with memory impairment in oldest-old Alzheimer's disease patients.在高龄阿尔茨海默病患者中,右侧顶上小叶与楔前叶的分离与记忆障碍有关。
Heliyon. 2020 Jul 22;6(7):e04516. doi: 10.1016/j.heliyon.2020.e04516. eCollection 2020 Jul.
10
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.MCLENA - 1:一项评估来那度胺对阿尔茨海默病所致轻度认知障碍患者安全性、耐受性和疗效的II期临床试验。
Open Access J Clin Trials. 2020;12:1-13. doi: 10.2147/oajct.s221914. Epub 2020 Jan 7.